Jason Hoitt - 17 Mar 2026 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Reporting relationship: Chief Patient Officer
Issuer ticker: STOK
Reported as of: 17 Mar 2026
Net transaction value: -$119,311
SEC form: 4
Accepted by SEC: 19 Mar 2026, 17:58:41 UTC
Prior SEC filing: 17 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Allan, Attorney-in-Fact

Key filing fact

Jason Hoitt filed Form 4 for Stoke Therapeutics, Inc. (STOK) on 19 Mar 2026.

Key facts

This page summarizes Jason Hoitt's Form 4 filing for Stoke Therapeutics, Inc. (STOK).
5 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 19 Mar 2026, 17:58.

Change

Previous filing in this sequence was filed on 17 Mar 2026.
Current net transaction value: -$119,311.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001762572 Primary reporting owner

Hoitt Jason

Relationship: Chief Patient Officer
Address: C/O STOKE THERAPEUTICS, INC., 45 WIGGINS AVENUE, BEDFORD
Signature: /s/ Jonathan Allan, Attorney-in-Fact
Signature date: 19 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STOK transaction

Common Stock

Sale

Transaction value: $33,820
Shares: -1,033
Change %: -7.4%
Price: $32.74
Shares after: 12,955
Date: 17 Mar 2026
Ownership: Direct
Footnotes: F1, F2

STOK transaction

Common Stock

Sale

Transaction value: $24,965
Shares: -748
Change %: -5.8%
Price: $33.38
Shares after: 12,207
Date: 17 Mar 2026
Ownership: Direct
Footnotes: F1, F3

STOK transaction

Common Stock

Sale

Transaction value: $55,122
Shares: -1,762
Change %: -14%
Price: $31.28
Shares after: 10,445
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1, F4

STOK transaction

Common Stock

Sale

Transaction value: $4,419
Shares: -139
Change %: -1.3%
Price: $31.79
Shares after: 10,306
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1, F5

STOK transaction

Common Stock

Sale

Transaction value: $986
Shares: -30
Change %: -0.29%
Price: $32.85
Shares after: 10,276
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units.

Footnote F2

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.995 to $32.99 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 5 of this Form 4.

Footnote F3

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.855 per share, inclusive.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.59 to $31.58 per share, inclusive.

Footnote F5

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $32.46 per share, inclusive.